Post-treatment human papillomavirus antibody kinetics in cervical cancer patients

Antibodies to the E6 and E7 oncoproteins of high-risk human papillomavirus (HPV) types are strongly associated with HPV-driven cancer, while antibodies against the capsid protein L1 are considered cumulative exposure markers. To test the hypothesis that L1 antibody levels are stable over time, where...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Piontek, Till (VerfasserIn) , Harmel, Christoph (VerfasserIn) , Pawlita, Michael (VerfasserIn) , Carow, Katrin (VerfasserIn) , Börner, Juliane (VerfasserIn) , Runnebaum, Ingo B. (VerfasserIn) , Dürst, Matthias (VerfasserIn) , Graw, Frederik (VerfasserIn) , Waterboer, Tim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 27 May 2019
In: Philosophical transactions of the Royal Society of London. Series B, Biological sciences
Year: 2019, Jahrgang: 374, Heft: 1773, Pages: 1-11
ISSN:2054-0280
DOI:10.1098/rstb.2018.0295
Online-Zugang:Verlag, Volltext: https://doi.org/10.1098/rstb.2018.0295
Volltext
Verfasserangaben:Till Piontek, Christoph Harmel, Michael Pawlita, Katrin Carow, Juliane Schröter, Ingo B. Runnebaum, Matthias Dürst, Frederik Graw and Tim Waterboer

MARC

LEADER 00000caa a2200000 c 4500
001 1671397347
003 DE-627
005 20231207081547.0
007 cr uuu---uuuuu
008 190814s2019 xx |||||o 00| ||eng c
024 7 |a 10.1098/rstb.2018.0295  |2 doi 
035 |a (DE-627)1671397347 
035 |a (DE-599)KXP1671397347 
035 |a (OCoLC)1341235737 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Piontek, Till  |d 1991-  |e VerfasserIn  |0 (DE-588)1192848012  |0 (DE-627)1671399536  |4 aut 
245 1 0 |a Post-treatment human papillomavirus antibody kinetics in cervical cancer patients  |c Till Piontek, Christoph Harmel, Michael Pawlita, Katrin Carow, Juliane Schröter, Ingo B. Runnebaum, Matthias Dürst, Frederik Graw and Tim Waterboer 
264 1 |c 27 May 2019 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht am 8. April 2019 
500 |a Gesehen am 14.08.2019 
520 |a Antibodies to the E6 and E7 oncoproteins of high-risk human papillomavirus (HPV) types are strongly associated with HPV-driven cancer, while antibodies against the capsid protein L1 are considered cumulative exposure markers. To test the hypothesis that L1 antibody levels are stable over time, whereas E6 and E7 levels undergo decay after cervical cancer (CxCa) treatment, we performed multiplex serology for HPV16 and 18 antigens E6, E7 and L1 in a post-treatment study of 184 patients with invasive CxCa that were characterized with a median follow-up time of 725 days, and 2–12 sera per patient. ... 
700 1 |a Harmel, Christoph  |e VerfasserIn  |0 (DE-588)122846717X  |0 (DE-627)1750223309  |4 aut 
700 1 |a Pawlita, Michael  |e VerfasserIn  |0 (DE-588)1135594724  |0 (DE-627)890509786  |0 (DE-576)489840140  |4 aut 
700 1 |a Carow, Katrin  |d 1988-  |e VerfasserIn  |0 (DE-588)1169709702  |0 (DE-627)1035341077  |0 (DE-576)512222665  |4 aut 
700 1 |a Börner, Juliane  |d 1982-  |e VerfasserIn  |0 (DE-588)142818690  |0 (DE-627)704318776  |0 (DE-576)333559398  |4 aut 
700 1 |a Runnebaum, Ingo B.  |d 1960-  |e VerfasserIn  |0 (DE-588)1111567727  |0 (DE-627)865636184  |0 (DE-576)476172144  |4 aut 
700 1 |a Dürst, Matthias  |d 1955-  |e VerfasserIn  |0 (DE-588)1111821518  |0 (DE-627)865930155  |0 (DE-576)169920372  |4 aut 
700 1 |a Graw, Frederik  |e VerfasserIn  |0 (DE-588)1133583717  |0 (DE-627)889501750  |0 (DE-576)488591945  |4 aut 
700 1 |a Waterboer, Tim  |e VerfasserIn  |0 (DE-588)119305494X  |0 (DE-627)1671578821  |4 aut 
773 0 8 |i Enthalten in  |t Philosophical transactions of the Royal Society of London. Series B, Biological sciences  |d London : [Verlag nicht ermittelbar], 1934  |g 374(2019), 1773, Artikel-ID 20180295, Seite 1-11  |h Online-Ressource  |w (DE-627)320507238  |w (DE-600)2012979-8  |w (DE-576)103939202  |x 2054-0280  |7 nnas  |a Post-treatment human papillomavirus antibody kinetics in cervical cancer patients 
773 1 8 |g volume:374  |g year:2019  |g number:1773  |g elocationid:20180295  |g pages:1-11  |g extent:11  |a Post-treatment human papillomavirus antibody kinetics in cervical cancer patients 
856 4 0 |u https://doi.org/10.1098/rstb.2018.0295  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190814 
993 |a Article 
994 |a 2019 
998 |g 119305494X  |a Waterboer, Tim  |m 119305494X:Waterboer, Tim  |d 140000  |e 140000PW119305494X  |k 0/140000/  |p 9  |y j 
998 |g 1133583717  |a Graw, Frederik  |m 1133583717:Graw, Frederik  |d 700000  |d 716000  |e 700000PG1133583717  |e 716000PG1133583717  |k 0/700000/  |k 1/700000/716000/  |p 8 
998 |g 1135594724  |a Pawlita, Michael  |m 1135594724:Pawlita, Michael  |d 140000  |e 140000PP1135594724  |k 0/140000/  |p 3 
998 |g 1192848012  |a Piontek, Till  |m 1192848012:Piontek, Till  |d 50000  |e 50000PP1192848012  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1671397347  |e 3507021102 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1671397347","origin":[{"dateIssuedDisp":"27 May 2019","dateIssuedKey":"2019"}],"physDesc":[{"extent":"11 S."}],"id":{"doi":["10.1098/rstb.2018.0295"],"eki":["1671397347"]},"note":["Online veröffentlicht am 8. April 2019","Gesehen am 14.08.2019"],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"London","publisher":"[Verlag nicht ermittelbar]","dateIssuedDisp":"1934-1990","dateIssuedKey":"1934"}],"recId":"320507238","note":["Gesehen am 27.09.2019"],"corporate":[{"display":"Royal Society","role":"isb"}],"id":{"eki":["320507238"],"issn":["2054-0280"],"zdb":["2012979-8"]},"disp":"Post-treatment human papillomavirus antibody kinetics in cervical cancer patientsPhilosophical transactions of the Royal Society of London. Series B, Biological sciences","physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["Vol. 224 (1934)-vol. 328 (1990)"],"part":{"volume":"374","year":"2019","text":"374(2019), 1773, Artikel-ID 20180295, Seite 1-11","pages":"1-11","extent":"11","issue":"1773"},"language":["eng"],"title":[{"title_sort":"Philosophical transactions of the Royal Society of London","title":"Philosophical transactions of the Royal Society of London","partname":"Biological sciences"}]}],"name":{"displayForm":["Till Piontek, Christoph Harmel, Michael Pawlita, Katrin Carow, Juliane Schröter, Ingo B. Runnebaum, Matthias Dürst, Frederik Graw and Tim Waterboer"]},"person":[{"given":"Till","role":"aut","display":"Piontek, Till","family":"Piontek"},{"given":"Christoph","role":"aut","display":"Harmel, Christoph","family":"Harmel"},{"display":"Pawlita, Michael","role":"aut","given":"Michael","family":"Pawlita"},{"role":"aut","given":"Katrin","display":"Carow, Katrin","family":"Carow"},{"given":"Juliane","role":"aut","display":"Börner, Juliane","family":"Börner"},{"display":"Runnebaum, Ingo B.","given":"Ingo B.","role":"aut","family":"Runnebaum"},{"family":"Dürst","given":"Matthias","role":"aut","display":"Dürst, Matthias"},{"family":"Graw","given":"Frederik","role":"aut","display":"Graw, Frederik"},{"display":"Waterboer, Tim","role":"aut","given":"Tim","family":"Waterboer"}],"title":[{"title":"Post-treatment human papillomavirus antibody kinetics in cervical cancer patients","title_sort":"Post-treatment human papillomavirus antibody kinetics in cervical cancer patients"}],"language":["eng"]} 
SRT |a PIONTEKTILPOSTTREATM2720